Retinal Capillary Vessel Density and Foveal Avascular Zone Size in Patients With Psoriatic Arthritis: A Case-Control Study. (PsA-RETINA)
Evaluation of Retinal Capillary Vascular Structures and the Foveal Avascular Zone in Patients With Psoriatic Arthritis.
In terms of blood flow per unit of tissue, the retina is one of the tissues with the highest blood flow in the body. Parameters such as the thickness of the choroid layer, which plays a crucial role in maintaining normal eye function, the dimensions of the foveal avascular zone (FAZ) supplied by this layer, and retinal vascular networks can be measured using non-invasive methods. OCTA (Optical Coherence Tomography Angiography) is an imaging tool that enables the non-invasive assessment of retinal microvascular densities and the measurement of the foveal avascular zone's dimensions. Studies conducted to date indicate that retinal capillary vessels and the dimensions of the foveal avascular zone are affected in rheumatological diseases, especially associated with systemic inflammation. This study aims to compare retinal capillary vessel density and foveal avascular zone dimensions in patients with psoriatic arthritis against those in a healthy population and in patients with psoriasis who do not have psoriatic arthritis, utilizing the non-invasive method of optical coherence tomography angiography.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
In terms of blood flow per unit of tissue, the retina is one of the tissues with the highest blood flow in the body. Non-invasive methods allow for the measurement of-and the detection of changes in-the thickness of the choroid layer (which plays a crucial role in maintaining normal eye function), the foveal avascular zone (nourished by this layer), and the retinal vascular networks. OCTA (Optical Coherence Tomography Angiography) is an imaging tool capable of non-invasively assessing retinal microvascular densities and measuring the dimensions of the foveal avascular zone. Retinal microvascular structures can be affected by systemic pathologies, including various eye diseases. In recent years, there has been growing evidence indicating that retinal vessel densities-as detected by OCTA-are significantly altered and the dimensions of the foveal avascular zone differ in patients with connective tissue diseases, vasculitis, and spondylitis. Psoriatic arthritis is a common chronic inflammatory disease characterized by both spondyloarthropathy and peripheral arthritis involvement. There is currently no data in the literature regarding the status of the choroidal vasculature-a highly perfused tissue-in patients with psoriatic arthritis or its relationship with disease activity. In this study, we aimed to compare retinal capillary density and foveal avascular zone dimensions among patients with psoriatic arthritis, patients with psoriasis, and healthy individuals using OCTA. The study will also compare findings between subgroups of psoriatic patients with and without concomitant spondylitis.
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Koray Ayar, Associated Proffessor
- Telefonnummer: 1648 +90 224-2955000
- E-post: ayarkoray@hotmail.com
Studieorter
-
-
Yıldırım
-
Bursa, Yıldırım, Turkiet (Türkiye), 16130
- Rekrytering
- University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital
-
Kontakt:
- Koray Ayar
- Telefonnummer: 05325618450
- E-post: ayarkoray@hotmail.com
-
Kontakt:
- Koray Ayar, Associated Proffessor (Dr.)
- Telefonnummer: 1648 +90 224-2955000
- E-post: ayarkoray@hotmail.com
-
Huvudutredare:
- Koray Ayar, Associated Proffessor (Dr.)
-
Underutredare:
- Neslihan Parmak Yener, Associated Proffessor
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
The study population consists of volunteers from among patients with psoriatic arthritis who are being followed at the study center's rheumatology clinic. The patient control group comprises volunteers diagnosed with psoriasis by a specialist dermatologist. Participants in the healthy control group are healthcare workers or patient companions matched for age and gender with the patient group and the patient control group.
Beskrivning
Inclusion Criteria:
- Volunteers diagnosed with psoriatic arthritis according to CASPAR criteria
- Volunteers diagnosed with psoriasis by a specialist dermatologist
- Hospital staff or patient companions with no chronic illnesses
Exclusion Criteria:
- Diabetes mellitus
- Cancer
- Pregnancy or lactation
- Chronic renal failure
- Glocome
- History of eye surgery
- History of eye trauma
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: CASE_CONTROL
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Psoriatic arthritis
Participants with psoriatic arthritis |
Vessel density of retinal superficial capillary plexus Vessel density of retinal deep capillary plexus Vessel density of retinal prepapillary capillaries FAZ essessment parameters |
|
Psoriasis
Psoriasis participants with no other known systemic inflammatory disease |
Vessel density of retinal superficial capillary plexus Vessel density of retinal deep capillary plexus Vessel density of retinal prepapillary capillaries FAZ essessment parameters |
|
Healthy controls
Patient companions or hospital staff with no known chronic illnesses |
Vessel density of retinal superficial capillary plexus Vessel density of retinal deep capillary plexus Vessel density of retinal prepapillary capillaries FAZ essessment parameters |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Retinal SCP, VD
Tidsram: 1 day
|
Vessel density of retinal superficial capillary plexus |
1 day
|
|
Retinal DCP, VD
Tidsram: 1 day
|
Vessel density of retinal deep capillary plexus |
1 day
|
|
Retinal RCP, VD
Tidsram: 1 day
|
Vessel density of retinal prepapillary capillaries |
1 day
|
|
FAZ parameters
Tidsram: 1 day
|
Foveal avasculary assessment parameters |
1 day
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2024-TBEK 2026/09-01
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .